Industry leading team

At Polpharma Biologics our passion for excellence begins at the top.

With decades of combined experience in the development, manufacture and commercialization of biopharmaceuticals, our international management team brings both knowledge and passion to every project.

Jerzy Starak

Founder and Owner Polpharma Biologics Group

Jerzy Starak is one of the Polish entrepreneurs whose activities contributed to the modernization and innovative development of the Polish economy. A visionary full of courage and determination in realizing ever new business challenges.

Jerzy Starak played a key role in the development of the Polish pharmaceutical sector. In 2000, he became the owner of Polpharma S.A. Ambitious modernization processes, huge investments in research and laboratory infrastructure and cooperation with top class specialists made Polpharma S.A. a European leader in the production of generic drugs.

In 2010, Jerzy Starak, inspired by the global direction in pharmaceutical development, made the decision to expand his business activities into production of biological drugs. Already in 2012, the first Research and Development Center opened in the Gdańsk Science and Technology Park and in 2020 another modern Center for Development and Production on an industrial scale began its activities in Warsaw-Duchnice. Today, Polpharma Biologics is the largest biosimilar drug development company in this part of Europe, operating in partnerships with global leaders in the pharmaceutical market.

Supervisory Board Polpharma Biologics Group

“We are experts in managing projects, transparent communicators and always deliver on our commitments”

Next
Dr Georg Nederegger

Chairman, Polpharma Biologics Group

“We are passionate about getting safe and effective medicines to patients”

Next
Dr Joerg Windisch

Vice Chairman, Polpharma Biologics Group

“We value everyone equally and always treat each other with respect”

Next
Dr Michel Cup

Supervisory Board Member, Polpharma Biologics Group

“We care about being respectful and transparent”

Next
Dr Konstantin Matentzoglu

Supervisory Board Member, Polpharma Biologics Group

“We work with dedication and find innovative solutions”

Next
Gertjan Noordermeer

Supervisory Board Member, Polpharma Biologics Group

Leaders Polpharma Biologics Group

“We care about being respectful and transparent”

Next
Dr Michael Soldan

CEO, Polpharma Biologics Group

"We like to collaborate and can rely on each other"

Next
Piotr Korycki

President of the Management Board (WAW and GDS), Polpharma Biologics Group

“We work with dedication and find innovative solutions”

Next
Frederic Papp

Chief Technical Officer, Polpharma Biologics Group

"We care about delivering on our commitments"

Next
Hannes Teissl

Chief Business Officer, Polpharma Biologics Group

“We are experts in managing projects, transparent communicators and always deliver on our commitments”

Next
Alexandra Moulson

Chief Development Officer, Polpharma Biologics Group

“Our patients expect and deserve high quality and innovative medicines”

Next
Mathieu Ballie

Chief Quality Officer, Polpharma Biologics Group

“We are passionate about getting safe and effective medicines to patients”

Next
Jakub Walkowiak

Chief Financial Officer, Polpharma Biologics Group

“We value everyone equally and always treat each other with respect ”

Next
Lidia Ołowska

VP P&O, Polpharma Biologics Group

“We care about being respectful and transparent”

Next
Agnieszka Kosowska

General Counsel, Polpharma Biologics Group

Site Heads

“We work with dedication and find innovative solutions”

Next
Dr Adriana Kiędzierska-Mencfeld

Site Head, Polpharma Biologics Gdańsk

"We like to collaborate and can rely on each other"

Next
Dr Jorge García de Ancos

Site Head, Polpharma Biologics Warsaw

“We anticipate potential issues before they arise, always ensuring high quality outcomes”

Next
Jonathan Robinson

Site Head, Polpharma Biologics Utrecht

Let’s collaborate and deliver quality biosimilars together.

Get in touch for more information.